ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

NCI To Recomplete CIDAC Contracts

September 23, 1977

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

Clinton To Propose $1 Billion Increase And A New Minority Health Center For NIH.

January 21, 2000

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

National Breast Cancer Coalition Seeks Nominations For “Golden Boob Award.”

May 12, 2006